Aurora Kinase A: Integrating Insights into Cancer, Inflammation, and Infectious Diseases
Open Access
- 24 October 2024
- journal article
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 1 (1)
Abstract
Aurora kinase A (AURKA) is crucial in regulating cell division and maintaining genomic stability, making it significant in cancer biology. This review explores AURKA’s structural and functional roles, emphasizing its involvement in cell cycle progression. Beyond cancer, AURKA emerges as a multifaceted player in host cell modulation, exerting influence over inflammatory responses, cell death mechanisms, and autophagy pathways. Moreover, recent research highlights its involvement in viral and bacterial infections. Numerous viruses, for their replication and assembly, modulate host cell cycle progression. Various viruses modulated AURKA to induce viral-mediated tumor. It also emerged as a key modulator in various gut microbiome-mediated cancers. Further, it also imparts oncogenic effect by modulation in cytoplasmic and mitochondrial regions of the cell. It hampers DNA replication independent of its kinase domain. Understanding AURKA’s diverse roles underscores its potential as a promising drug target, offering therapeutic avenues for various diseases. This comprehensive exploration navigates through complex landscape of AURKA biology, paving way for future investigations and therapeutic interventions.Keywords
Funding Information
- Anusandhan National Research Foundation (EMR/2017/001637)
- Indian Council of Medical Research (no. BMI/12(82)/2021)
- DST as Ramanujan Fellowship ((SB/S2/RJN-132/20/5))
This publication has 141 references indexed in Scilit:
- SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1Apoptosis, 2023
- Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancerCancer Communications, 2021
- Insights into the non-mitotic functions of Aurora kinase A: more than just cell divisionCellular and Molecular Life Sciences, 2019
- Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancerBreast Cancer Research and Treatment, 2019
- A phase 1 study of AMG 900, an orally administered pan‐aurora kinase inhibitor, in adult patients with acute myeloid leukemiaAmerican Journal of Hematology, 2017
- Aurora‐A Kinase: A Potent Oncogene and Target for Cancer TherapyMedicinal Research Reviews, 2016
- Host genetics of Epstein–Barr virus infection, latency and diseaseReviews in Medical Virology, 2014
- NCIC CTG IND.181: Phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignanciesInvestigational New Drugs, 2013
- Tumor resistance to apoptosisInternational Journal of Cancer, 2008
- Historical insights into cytokinesEuropean Journal of Immunology, 2007